Microcirculation in Continuous Venovenous Hemofiltration Patients on the Intensive Care Unit
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
In patients where fluid is withdrawn from the bloodstream by Continuous Venovenous Hemofiltration (CVVH), the ultrafiltration rate will be calculated for a zero balance. From there, the ultrafiltration steps are performed, after increasing the ultrafiltration rate, the sublingual microcirculation is assessed by sidestream dark field (SDF). The images are subsequently randomly analyzed, and the sublingual microcirculation is expressed as a number, the microvascular flow index (MFI).
| Condition |
|---|
|
Continuous Venovenous Hemofiltration |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Evaluation of Sublingual Microcirculation by Means of SDF Imaging by Stepwise Ultrafiltration in CVVH Patients on the ICU |
- Difference in MFI between zero balance and maximal ultrafiltrationrate (300 ml/hr) [ Time Frame: 4 hours ] [ Designated as safety issue: No ]-
| Enrollment: | 14 |
| Study Start Date: | September 2011 |
| Study Completion Date: | October 2012 |
| Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| CVVH patients |
Detailed Description:
Before deciding to threat a patient actively with CVVH, a target balance will be agreed for the next 12 hours. Then the ultrafiltration rate for the zero balance is calculated. From there, the ultrafiltration rate progressively increased to 50 ml per hour, up to a maximum ultrafiltration rate of 300 ml per hour.
After each increase of the ultrafiltration rate, the sublingual microcirculation is assessed by SDF.
After obtaining the desired ultrafiltration rate, the microcirculation will again be assessed before and after the patient is temporarily placed in Trendelenburg position. This could possibly show that underfill has the greatest influence on the microcirculation, and not other factors like a rising hematocrit.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Intensive Care patients treated with CVVH
Inclusion Criteria:
- age > 18 jaar
- informed consent
Exclusion Criteria:
- age < 18 jaar
- oral surgery
Contacts and Locations
More Information
Publications:
| Responsible Party: | E.C. Boerma, Dr, Medical Centre Leeuwarden |
| ClinicalTrials.gov Identifier: | NCT01362088 History of Changes |
| Other Study ID Numbers: | TPO 767 |
| Study First Received: | May 11, 2011 |
| Last Updated: | October 31, 2012 |
| Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Keywords provided by Medical Centre Leeuwarden:
|
microcirculation intensive care ultrafiltration CVVH |
ClinicalTrials.gov processed this record on May 16, 2013